Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MEDASSETS INC (MDAS)
|
Add to portfolio |
|
|
|
| Price: |
$31.35
| | Metrics |
| OS: |
59.3
|
M
| |
-8
|
% ROE
|
| Market cap: |
$1.86
|
B
| |
65
|
% ROIC
|
|
Net debt:
|
$526
|
M
| |
3.3
|
x Debt/EBITDA
|
|
EV:
|
$2.38
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$158
|
M
| |
15.1
|
x EV/EBITDA
|
|
EBIT
|
$97.2
|
M
| |
24.5
|
x EV/EBIT
|
| EPS |
($0.59)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 720.2 | 680.4 | 640.1 | 578.3 | 391.3 | 341.3 | 279.7 | 188.5 |
| Revenue growth | 5.9% | 6.3% | 10.7% | 47.8% | 14.7% | 22.0% | 48.3% | 28.9% |
| Cost of goods sold | 175.0 | 154.1 | 141.0 | 121.8 | 100.7 | 74.7 | 51.5 | 28.0 |
| Gross profit | 545.2 | 526.3 | 499.1 | 456.5 | 290.6 | 266.6 | 228.1 | 160.5 |
| Gross margin | 75.7% | 77.4% | 78.0% | 78.9% | 74.3% | 78.1% | 81.6% | 85.2% |
| Sales and marketing | 67.4 | 61.4 | 60.4 | 57.0 | 46.7 | 45.3 | 43.2 | 35.7 |
| Research and development | 31.1 | 30.9 | 28.5 | 26.8 | 20.0 | 19.0 | 16.4 | 7.8 |
| General and administrative | 237.6 | 231.8 | 218.2 | 203.1 | 124.4 | 110.7 | 91.5 | 64.8 |
| EBITA | 156.6 | 153.5 | 158.4 | 147.7 | 80.2 | 79.2 | 68.1 | 44.7 |
| EBITA margin | 21.7% | 22.6% | 24.7% | 25.5% | 20.5% | 23.2% | 24.4% | 23.7% |
| Amortization of intangibles | 57.6 | 62.7 | 73.2 | 81.1 | 31.7 | 28.8 | 24.3 | 16.6 |
| EBIT | 99.0 | 90.7 | 85.2 | 66.7 | 48.5 | 50.5 | 43.8 | 28.1 |
| EBIT margin | 13.7% | 13.3% | 13.3% | 11.5% | 12.4% | 14.8% | 15.7% | 14.9% |
| Pre-tax income | 1.2 | 44.1 | -8.4 | -25.3 | -46.4 | 32.8 | 18.3 | 10.8 |
| Income taxes | 21.6 | 16.7 | -1.5 | -9.9 | -14.3 | 12.8 | 7.5 | 4.5 |
| Tax rate | 1781.0% | 37.8% | 17.7% | 38.9% | 30.7% | 39.1% | 40.9% | 41.8% |
| Net income | -20.4 | 27.4 | -6.9 | -15.5 | -32.1 | 19.9 | 10.8 | 0.0 |
| Net margin | -2.8% | 4.0% | -1.1% | -2.7% | -8.2% | 5.8% | 3.9% | 0.0% |
| |
| Diluted EPS | ($0.34) | $0.45 | ($0.12) | ($0.27) | ($0.57) | $0.34 | $0.21 | ($0.75) |
| Shares outstanding (diluted) | 59.8 | 61.2 | 57.5 | 57.3 | 56.4 | 57.9 | 52.3 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|